Vaginal cancer natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
{{CMG}}
{{CMG}}
{{Vaginal cancer}}
{{Vaginal cancer}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


==Overview==
==Overview==
Line 13: Line 15:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Gynecology]]
[[Category:Oncology]]

Revision as of 14:23, 18 September 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Vaginal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vaginal cancer natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer natural history

CDC on Vaginal cancer natural history

Vaginal cancer natural history in the news

Blogs on Vaginal cancer natural history

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer natural history

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Natural History

Complications

Prognosis

Prognosis depends primarily on the stage of disease, but survival is reduced in patients who are greater than 60 years of age, are symptomatic at the time of diagnosis, have lesions of the middle and lower third of the vagina, or have poorly differentiated tumors. In addition, the length of vaginal wall involvement has been found to be significantly correlated to survival and stage of disease in squamous cell carcinoma patients.

References